Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117218) titled 'A retrospective cohort study based on real-world data evaluating the efficacy and safety of PD-1/PD-L1 inhibitors combined with gemcitabine/cisplatin versus gemcitabine/cisplatin alone as first-line treatment for advanced intrahepatic cholangiocarcinoma' on Jan. 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Ningbo Medical Centre Lihuili Hospital
Condition:
intrahepatic cholangicarcinoma
Intervention:
Immunotherapy combined with chemotherapy group :N/A
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-22
Target Sample Size: Immunotherapy co...